Browsing by Author "Erkol, Burçak"
Now showing items 1-6 of 6
-
Capecitabine-cisplatin versus 5-fluorouracil/leucovorin in combination with radiotherapy for adjuvant therapy of lymph node positive locally advanced gastric cancer
Öven Ustaalioğlu, Bala Başak; Bilici, Ahmet; Tilki, Metin; Sürmelioğlu, Ali; Erkol, Burçak; Figen, Metin; Uyar, Serab (Wolters Kluwer Medknow Publications, 2018)Aim of the Study: Although surgery is considered to be curative treatment, recurrence rates are high in gastric cancer. Adjuvant 5-fluorouracil (5-FU) based chemoradiotherapy has been shown to improve the prognosis. We ... -
Clinical importance of discordance in hormone receptor and HER2/NEU status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut (Elsevier, 2014)Aim: Neoadjuvant chemotherapy (NAC) is used longer for both locally advanced breast cancer and early stage to increase breast conservation. Discordance of the hormone receptor (HR) status was reported to be 8-33% of the ... -
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut; Aliustaoglu, Mehmet (Zerbinis Medical Publications, 2014)Purpose: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), ... -
The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
Öven Ustaalioğlu, Bala Başak; Balvan, Özlem; Bilici, Ahmet Erkan; Develi, Ahmet Çağrı; Aliustaoǧlu, Mehmet; Vardar, Fugen; Erkol, Burçak (Springer-Verlag, 2015)In the literature, small number of study has addressed time of recurrence in breast cancer. We analyzed clinicopathological factors predicting early or late recurrence in breast cancer patients and also prognostic factors ... -
Prognostic factors for operated gallbladder cancer
Öven Ustaalıoğlu, Bala Başak; Bilici, Ahmet Erkan; Şeker, Mesut Metin; Kefeli, Umut; Aydın, Dinçer; Çelik, Serkan; Demir, Tarık; Erkol, Burçak (Humana Press Inc., 2019)Purpose: The prognosis of gallbladder cancer is poor. Lymph node metastasis and the stage are known to be the strongest prognostic factors for survival. The aim of this study was to determine the importance of complementary ... -
Prognostic markers for metastatic colon cancer patients undergoing multiple metastasectomies
Ustaalioğlu, Bala Başak Öven; Tilki, Metin; Kılıçoğlu, Zeynep Gamze; Bilici, Ahmet; Sürmelioğlu, Ali; Ustaalioğlu, Recep; Erkol, Burçak (Aves, 2015)Background/Aims: Following metastasis resection, 5-year survival rate has been reported as approximately 40%. There is no consensus regarding prognostic factors related to progression-free survival after repeated ...
